| Dr Alden Kirk Haun, MD | |
|
628 Smithview Dr, Maryville, TN 37803 | |
| (865) 984-7012 | |
| (865) 584-3892 |
| Full Name | Dr Alden Kirk Haun |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 27 Years |
| Location | 628 Smithview Dr, Maryville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316941842 | NPI | - | NPPES |
| 3371152 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 34217 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Campbell Cunningham Taylor Pc | 0244216562 | 18 |
News Archive
Today's headlines include stories that look back and examine the role of the health overhaul in creating the 2010 political climate, as well as reports that look forward to what changes are in store for 2011.
Ovarian Cancer Australia has found less than one per cent of women know they're at risk if there's a family history of ovarian cancer on their father's side. And only 42 per cent know a history on their mother's side puts them at increased risk.
Feeling sluggish? Gaining weight? What you need is a shot in the arm, claim advertisers for trendy vitamin B12 injections.
Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has signed a contract valued at up to $153 million over five years with the Biomedical Advanced Research and Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response of the Department of Health and Human Services, to develop CLT-008, a cellular therapy for the treatment of Acute Radiation Syndrome (ARS).
› Verified 5 days ago
| Entity Name | Campbell Cunningham Taylor Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407850944 PECOS PAC ID: 0244216562 Enrollment ID: O20040628000593 |
News Archive
Today's headlines include stories that look back and examine the role of the health overhaul in creating the 2010 political climate, as well as reports that look forward to what changes are in store for 2011.
Ovarian Cancer Australia has found less than one per cent of women know they're at risk if there's a family history of ovarian cancer on their father's side. And only 42 per cent know a history on their mother's side puts them at increased risk.
Feeling sluggish? Gaining weight? What you need is a shot in the arm, claim advertisers for trendy vitamin B12 injections.
Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has signed a contract valued at up to $153 million over five years with the Biomedical Advanced Research and Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response of the Department of Health and Human Services, to develop CLT-008, a cellular therapy for the treatment of Acute Radiation Syndrome (ARS).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alden Kirk Haun, MD 1124 E Weisgarber Rd, Ste 104, Knoxville, TN 37909-2686 Ph: (865) 584-0905 | Dr Alden Kirk Haun, MD 628 Smithview Dr, Maryville, TN 37803 Ph: (865) 984-7012 |
News Archive
Today's headlines include stories that look back and examine the role of the health overhaul in creating the 2010 political climate, as well as reports that look forward to what changes are in store for 2011.
Ovarian Cancer Australia has found less than one per cent of women know they're at risk if there's a family history of ovarian cancer on their father's side. And only 42 per cent know a history on their mother's side puts them at increased risk.
Feeling sluggish? Gaining weight? What you need is a shot in the arm, claim advertisers for trendy vitamin B12 injections.
Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has signed a contract valued at up to $153 million over five years with the Biomedical Advanced Research and Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response of the Department of Health and Human Services, to develop CLT-008, a cellular therapy for the treatment of Acute Radiation Syndrome (ARS).
› Verified 5 days ago
Julie Ross Durand, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 622 Smithview Dr, Maryville, TN 37803 Phone: 865-681-1234 Fax: 865-982-9746 | |
Kenneth W Olander, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 622 Smithview Dr, Maryville, TN 37803 Phone: 865-681-1234 Fax: 865-982-9746 |